Skip to main content

Part of the book series: Key Topics in Brain Research ((KEYTOPICS))

  • 139 Accesses

Summary

Biogenic amines and their metabolites in lumbar CSF and serum from 43 patients did not significantly differ between dementia of Alzheimer’s type (DAT), Binswanger’s disease (BD), multiinfarct dementia (MID) and Parkinson’s disease (PD). The only significant finding was elevated CSF 5-hydroxyindoleacetic acid (5HIAA) in DAT patients treated with neuroleptics relative to the other groups. The values found in a small number of patients with Pick’s, Huntington’s (CH) and Creutzfeldt-Jacob’s (CJ) disease were within the range of the other groups. CSF lactate, measured in 28 of the patients, tended to be elevated in vascular dementia (BD, MID). A crude estimate of cognitive impairment showed correlations to inner and outer brain atrophy in CT-scans. There were, however, no definite correlations between clinical impairments and CSF or serum findings.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Beal MF, Growdon JH (1986) CSF neurotransmitter markers in Alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry 10: 259–270

    Article  PubMed  CAS  Google Scholar 

  • Cummings JL (1986) Subcortical dementia. Br J Psychiatry 149: 682–697

    Article  PubMed  CAS  Google Scholar 

  • Davidson M, Giordani AB, Mohs RC, Mykytyn VV, Platt S, Aryan ZS, Davis KL (1987) Control of exogenous factors affecting plasma homovanillic acid concentration. Psychiatry Res 20: 307–312

    Article  PubMed  CAS  Google Scholar 

  • Gibb WRG (1989) Dementia and Parkinson’s disease. Br J Psychiatry 154: 596614

    Google Scholar 

  • Gibson CJ, Logue M, Growdon MD (1985) CSF monoamine metabolite levels in Alzheimer’s and Parkinson’s disease. Arch Neurol 42: 489–492

    Article  PubMed  CAS  Google Scholar 

  • Gottfries CG (1985) Alzheimer’s disease and senile dementia: biochemical characteristics and aspects of treatment. Psychopharmacology 86: 245–252

    Article  PubMed  CAS  Google Scholar 

  • Hollander E, Mohs RC, Davis KL (1986) Antemortem markers of Alzheimer’s disease. Neurobiol Aging 7: 367–387

    Article  PubMed  CAS  Google Scholar 

  • Kurlan R, Caine E, Rubin A, Nemeroff CB, Bissette G, Zaczek R, Coyle J, Spielman FJ, Irvine C, Shoulson I (1988) Cerebrospinal fluid correlates of depression in Huntington’s disease. Arch Neurol 45: 881–883

    Article  PubMed  CAS  Google Scholar 

  • Miller Fisher C (1989) Binswanger’s encephalopathy: a review. J Neurol 256: 65–79

    Article  Google Scholar 

  • Mann MA, Yates PO (1986) Neurotransmitter deficits in Alzheimer’s disease and in other dementing disorders. Human Neurobiol 5: 147–158

    CAS  Google Scholar 

  • Palmer AM, Sims NR, Bowen DM, Neary D, Palo J, Wikstrom J, Davison AN (1984) Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer’s dementia. J Neurol Neurosurg Psychiatry 47: 481–484

    Article  PubMed  CAS  Google Scholar 

  • Riederer P, Rausch WD, Schmidt B, Kruzik P, Konradi C, Sofic E, Danielczyk W (1988) Biochemical fundamentals of Parkinson’s disease. Mt Sinai J Med (NY) 55: 21–28

    CAS  Google Scholar 

  • Rossor M (1988) Neurochemical studies in dementia. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 20. Psychopharmacology of the aging nervous system. Plenum Press, New York London, pp 107 —130

    Google Scholar 

  • Sanberg PR, Coyle JT (1984) Scientific approaches to Huntington’s disease. Crit Rev Clin Neurobiol 1: 1–44

    CAS  Google Scholar 

  • Sofic E (1986) Untersuchungen von biogenen Aminen, Metaboliten, Ascorbinsäure und Glutathion mittels HPLC-ECD und deren Verhalten in ausgewählten Lebensmitteln und im Organismus von Mensch und Tier. Thesis, TU Vienna

    Google Scholar 

  • Turkka JV, Juujärvi KK, Lapinlampi TO, Myllylä VV (1986) Serum nor-adrenaline response to standing up in patients with Parkinson’s disease. Eur Neurol 25:355 —361

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Wien

About this chapter

Cite this chapter

Sofic, E., Fritze, J., Schnaberth, G., Bruck, J., Riederer, P. (1990). Neurodegenerative diseases: CSF amines, lactate and clinical findings. In: Maurer, K., Riederer, P., Beckmann, H. (eds) Alzheimer’s Disease. Epidemiology, Neuropathology, Neurochemistry, and Clinics. Key Topics in Brain Research. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3396-5_34

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-3396-5_34

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82197-8

  • Online ISBN: 978-3-7091-3396-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics